Professional Compounding Centers of America   Report issue

For profit Phase 2
Founded: Houston TX United States (1981)
Status: No NME R&D (1981)

Organization Overview

First Clinical Trial
2018
NCT03461354
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Professional Compounding Centers of America

Active Ingredients

Drugs in Phase 2 Trials (2)

dexamethasone (1 trial)

sodium bicarbonate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Head and Neck Neoplasms (Phase 2)

Mucositis (Phase 2)

Stomatitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2